東和薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/04 | 2,542 | 2,573 | 2,496 | 2,530 | -57 | -2.2% | 170,300 |
| 2025/04/03 | 2,550 | 2,602 | 2,532 | 2,587 | -43 | -1.6% | 167,600 |
| 2025/04/02 | 2,701 | 2,709 | 2,630 | 2,630 | -70 | -2.6% | 99,000 |
| 2025/04/01 | 2,692 | 2,715 | 2,688 | 2,700 | +21 | +0.8% | 84,300 |
| 2025/03/31 | 2,720 | 2,729 | 2,674 | 2,679 | -64 | -2.3% | 198,600 |
| 2025/03/28 | 2,771 | 2,779 | 2,743 | 2,743 | -55 | -2% | 82,800 |
| 2025/03/27 | 2,775 | 2,798 | 2,765 | 2,798 | -4 | -0.1% | 84,700 |
| 2025/03/26 | 2,802 | 2,815 | 2,791 | 2,802 | +2 | +0.1% | 86,600 |
| 2025/03/25 | 2,790 | 2,812 | 2,771 | 2,800 | +10 | +0.4% | 71,700 |
| 2025/03/24 | 2,820 | 2,820 | 2,750 | 2,790 | -12 | -0.4% | 154,900 |
| 2025/03/21 | 2,780 | 2,816 | 2,780 | 2,802 | +24 | +0.9% | 106,000 |
| 2025/03/19 | 2,770 | 2,790 | 2,767 | 2,778 | +8 | +0.3% | 64,700 |
| 2025/03/18 | 2,765 | 2,776 | 2,755 | 2,770 | +10 | +0.4% | 121,100 |
| 2025/03/17 | 2,762 | 2,783 | 2,756 | 2,760 | -2 | -0.1% | 75,200 |
| 2025/03/14 | 2,730 | 2,780 | 2,725 | 2,762 | +11 | +0.4% | 115,300 |
| 2025/03/13 | 2,791 | 2,791 | 2,735 | 2,751 | -58 | -2.1% | 151,900 |
| 2025/03/12 | 2,692 | 2,819 | 2,688 | 2,809 | +97 | +3.6% | 249,800 |
| 2025/03/11 | 2,740 | 2,757 | 2,672 | 2,712 | -70 | -2.5% | 197,800 |
| 2025/03/10 | 2,821 | 2,828 | 2,773 | 2,782 | -39 | -1.4% | 150,200 |
| 2025/03/07 | 2,857 | 3,050 | 2,781 | 2,821 | -71 | -2.5% | 547,200 |
| 2025/03/06 | 2,929 | 2,953 | 2,876 | 2,892 | -30 | -1% | 102,500 |
| 2025/03/05 | 2,881 | 2,938 | 2,860 | 2,922 | +41 | +1.4% | 147,600 |
| 2025/03/04 | 2,924 | 2,999 | 2,874 | 2,881 | +57 | +2% | 276,600 |
| 2025/03/03 | 2,837 | 2,855 | 2,822 | 2,824 | +34 | +1.2% | 98,900 |
| 2025/02/28 | 2,848 | 2,862 | 2,777 | 2,790 | -50 | -1.8% | 150,300 |
| 2025/02/27 | 2,860 | 2,864 | 2,839 | 2,840 | -8 | -0.3% | 49,500 |
| 2025/02/26 | 2,835 | 2,853 | 2,813 | 2,848 | +9 | +0.3% | 103,300 |
| 2025/02/25 | 2,811 | 2,853 | 2,804 | 2,839 | +13 | +0.5% | 103,300 |
| 2025/02/21 | 2,838 | 2,856 | 2,804 | 2,826 | -29 | -1% | 142,600 |
| 2025/02/20 | 2,903 | 2,903 | 2,835 | 2,855 | -65 | -2.2% | 109,800 |
| 2025/02/19 | 2,968 | 3,010 | 2,920 | 2,920 | -74 | -2.5% | 99,900 |
| 2025/02/18 | 2,998 | 3,020 | 2,957 | 2,994 | -26 | -0.9% | 93,700 |
| 2025/02/17 | 3,035 | 3,075 | 3,010 | 3,020 | ±0 | ±0% | 84,500 |
| 2025/02/14 | 3,100 | 3,115 | 2,951 | 3,020 | -10 | -0.3% | 258,500 |
| 2025/02/13 | 3,010 | 3,050 | 3,005 | 3,030 | +71 | +2.4% | 132,500 |
| 2025/02/12 | 2,947 | 2,991 | 2,930 | 2,959 | +40 | +1.4% | 164,600 |
| 2025/02/10 | 2,916 | 2,932 | 2,902 | 2,919 | +10 | +0.3% | 84,000 |
| 2025/02/07 | 2,902 | 2,924 | 2,883 | 2,909 | -10 | -0.3% | 61,900 |
| 2025/02/06 | 2,926 | 2,942 | 2,893 | 2,919 | +29 | +1% | 80,200 |
| 2025/02/05 | 2,905 | 2,917 | 2,865 | 2,890 | -15 | -0.5% | 107,500 |
| 2025/02/04 | 2,940 | 2,950 | 2,894 | 2,905 | -10 | -0.3% | 106,600 |
| 2025/02/03 | 2,984 | 2,984 | 2,910 | 2,915 | -100 | -3.3% | 154,300 |
| 2025/01/31 | 3,040 | 3,040 | 3,005 | 3,015 | -40 | -1.3% | 57,600 |
| 2025/01/30 | 3,045 | 3,080 | 3,040 | 3,055 | +25 | +0.8% | 88,900 |
| 2025/01/29 | 3,070 | 3,080 | 3,030 | 3,030 | -30 | -1% | 59,500 |
| 2025/01/28 | 3,055 | 3,080 | 3,045 | 3,060 | -10 | -0.3% | 54,500 |
| 2025/01/27 | 3,070 | 3,080 | 3,050 | 3,070 | +20 | +0.7% | 75,700 |
| 2025/01/24 | 3,060 | 3,100 | 3,040 | 3,050 | +15 | +0.5% | 98,800 |
| 2025/01/23 | 3,000 | 3,050 | 2,973 | 3,035 | ±0 | ±0% | 121,900 |
| 2025/01/22 | 3,065 | 3,065 | 3,015 | 3,035 | -20 | -0.7% | 97,200 |
1～
50
件表示中 / 6926件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 科研薬 | 444,100円 | +22.8% | +113.0% | 4.28% | 12.34倍 | 1.10倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
